R. Pérez-Álvarez

Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C

Manuel Romero‐Gómez, Emilio Gómez-González, R. Pérez-Álvarez et al. · Hepatology · 2007 · 58 citations · Full text

Medicine, Pathology, Radiology +17

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping

José Ramón Vidal-Castiñeira, Antonio López‐Vázquez, Rebeca Alonso‐Arias et al. · Journal of Hepatology · 2012 · 21 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

José Luís Calleja, J.M. Pascasio, Belén Ruíz‐Antorán et al. · Liver International · 2014 · 16 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome

José Ramón Vidal-Castiñeira, Antonio López‐Vázquez, Jesús Martı́nez-Borra et al. · PLoS ONE · 2014 · 14 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Undetectable <scp>HCV</scp>‐<scp>RNA</scp> at treatment‐week 8 results in high‐sustained virological response in <scp>HCV</scp> G1 treatment‐experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

Savino Bruno, S. Bollani, Anna Linda Zignego et al. · Journal of Viral Hepatitis · 2014 · 11 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17